| Trial Identifier: | D5180C00025 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Amgen
|
| NCTID:: | NCT04673630 |
| Start Date: | February 2021 |
| Primary Completion Date: | September 2022 |
| Study Completion Date: | September 2022 |
| Condition: | Asthma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Afrikaans Translation | |
| English Translation | |
| English (South Africa) Translation | |
| Hungarian Translation | |
| Xhosa Translation |
| Country | Location |
|---|---|
| GB | Bristol, GB, BS2 8BJ |
| GB | Glasgow, GB, G51 4TF |
| GB | London, GB, E1 1BB |
| GB | London, GB, SE5 9RS |
| HU | Budapest, HU, 1094 |
| ZA | Cape Town, ZA, 7700 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company